Edicotinib

N/A

Report date: 2026/04/29 17:38:02
NME

Base Information

Drug NameEdicotinib
Drug Alias NameEdicotinib hydrochloride (Janssen Research & Development)PRV-6527JNJ-244JNJ-527JNJ-40346527 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionColony stimulating factor 1 receptor inhibitors
TargetsColony stimulating factor 1 receptor
Therapy Area/IndicationsCognitive DysfunctionAlzheimer DiseaseCrohn Disease +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[17] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesThe University Of Texas MD Anderson Cancer Center
Inactive CompaniesJanssen Pharmaceutica SaJanssen, LpOhsu Knight Cancer Institute +[7] 
Active IndicationsProstatic Neoplasms
Inactive IndicationsCognitive DysfunctionAlzheimer DiseaseCrohn Disease +[6] 

Other Information

ATC CodeN/A
Related LinksN/A